Implementation of Empagliflozin in Patients with Diabetes Mellitus Type 2 and Established Cardiovascular Disease: Estimation of 5-Year Survival and Costs in Sweden

INTRODUCTION: Cardiovascular disease (CVD) affects approximately 30% of patients with diabetes mellitus type 2 (T2D) and leads to increased morbidity, decreased survival and increased healthcare utilization. The aim of this study was to estimate the impact of treating these patients with the sodium–...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernfort, Lars, Husberg, Magnus, Wiréhn, Ann-Britt, Rosenqvist, Ulf, Gustavsson, Staffan, Karlsdotter, Kristina, Levin, Lars-Åke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644727/
https://www.ncbi.nlm.nih.gov/pubmed/33021700
http://dx.doi.org/10.1007/s13300-020-00937-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644727/
https://www.ncbi.nlm.nih.gov/pubmed/33021700
http://dx.doi.org/10.1007/s13300-020-00937-4

Ejemplares similares